Seattle, WA – According to filings with the U.S. Securities and Exchange Commission, Cyrus Biotechnology is raising $15,942,168.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Lucas Nivon played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Cyrus Biotechnology
Cyrus Bio offers easy-to-use Computational Protein Engineering software on the cloud, accessed via a web-based GUI. We accelerate discovery and development in Biotech, Pharmaceuticals and Industrial Biotechnology. We use the Rosetta software package, developed by a large university consortium, to leverage the most advanced and validated in silico protein engineering science.

To learn more about Cyrus Biotechnology, visit http://cyrusbio.com/

Contact:
Lucas Nivon, Chief Executive Officer
206-258-6561
lucas.nivon@cyrusbio.com
https://www.linkedin.com/in/lucasnivon/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved